Novoxel Ltd.
Company-provided description, not an official-source fact. Certifications, capacities, years and market positions stated in it are the company's own claims until a record below confirms them.
Tixel - Traitement innovant pour le rajeunissement de la peau et la sécheresse oculaire
Découvrez Tixel® propulsé par la technologie TMA®. Resurfaçage cutané fractionné révolutionnaire avec une sécurité maximale et des effets secondaires minimes. Traitements rapides et efficaces pour les applications esthétiques et pour les yeux secs.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer (official record)
- Location
- Netanya, Israel
- Website
- https://novoxel.com
- Categories
- Fournitures médicales et de santé
- Markets
- Israël
Listed in a source registry
What is established and what is not
No researcher review has been written for this company yet. 2 official records from 2 official sources are on file. 1 other entry is not an official record: our own technical checks and searches, open directory listings, our inferences or the company's own statements. Everything is listed below with its evidence type: each entry confirms only what it literally says; none of them is a review. The manufacturing role above rests on the official records listed below, and only as far as each literally goes: a facility registration or licence is not an observation of current production. Nothing here confirms ownership or trading status beyond what each record literally says.
Facts on file, each with its evidence type
- Website domain registered (record type: domain-registered) [our own observation, not an official record; status green] Shows how long this web address has been registered. That is the age of the domain, not of the company: a domain can change owners. checked 2026-08-23. Domain registry record
- product-authorised-for-sale-holder (record type: product-authorised-for-sale-holder) [official record; status green] Applicant to the US FDA for 3 medical devices: Tixel i (TXLI0001) (K240512, 2024), Tixel® 2 System (K223033, 2023), Tixel System (K202988, 2021). The applicant answers for the notification; the record does not say who makes the device. A national regulator lists this company as the holder of the registration of products it has authorised for sale in that country. The holder answers for the product on that market; the record does not say the holder makes it. effective since 2026-10-05. FDA premarket notifications 510(k) and De Novo (openFDA, U.S. Food and Drug Administration)
- Registered as a manufacturer (record type: registered-manufacturer) [official record; status green] Its own declared activity in the register covers making these goods. checked 2026-10-03. ALIMS (Medicines and Medical Devices Agency of Serbia), register of medical-device manufacturers
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)